Ataraxis AI
@Ataraxis_AI
Transforming cancer care with AI precision medicine
Bạn có thể thích
Big day: Ataraxis raised a $20.4 million Series A from @aixventureshq, @peterthiel, and other top tier VC funds and angel investors, including OpenAI & DeepMind researchers. This funding round comes just a few months after we revealed Ataraxis Breast, the world's first AI-native…
Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that. tcrn.ch/3Xt7zTE
Missing SABCS? Join us Dec 16 at 5 PM EST for the Ataraxis SABCS Research Highlights Webinar. Get key insights from our 8 posters, new real-world Breast RISK data, first Breast NEO results, and updates from our AI lab. Registration Link: go.ataraxis.ai/webinar-sabcs2…
Big news ahead at #SABCS25! We will present eight new studies featuring real-world validation and utility of Ataraxis Breast RISK, head-to-head comparisons with genomic assays, and the first-ever data on Ataraxis Breast NEO, our new test for predicting response to neoadjuvant…
Ataraxis is growing and working on bringing Ataraxis Breast and other AI-native tools to clinicians and patients. Today, we’re introducing some of the outstanding new members who recently joined our commercial and medical teams: - John Benton (Oncology Specialist, prev. Artera)…
Today, we announce a strategic research collaboration between Ataraxis AI and MEDSIR (@wearemedsir), a global leader in oncology research. The partnership will evaluate the Ataraxis Breast platform in several international randomized controlled trials. Together, we aim to…
We are at the TME Fall Summit in New Orleans this week, giving breast surgeons and oncologists one of the first opportunities to learn about how Ataraxis Breast is used in practice. Schedule a call at go.ataraxis.ai/meet-tme25 or learn more at ataraxis.ai/breast
Next week, our CEO @JanWitowski will present the most recent Ataraxis Breast clinical validation results and deployment insights at the 18th International Symposium on Translational Research in Oncology: ccrt.ie/the-18th-inter…
Over the past few months, we’ve doubled the size of our team. Today, we’re excited to introduce some of the researchers joining our frontier AI lab, building next-generation models for precision medicine: - Jeroen Berrevoets (prev. Cambridge Math PhD) - Jungkyu (JP) Park (prev.…
🏆 Ataraxis won 1st place at the Nebius AI Discovery Awards! Out of 250+ global contenders innovating at the intersection of AI and life sciences, our team was honored to receive the top prize in the biotech category — and a $100,000 award — at the @nebiusai AI Discovery 2025…
We are at #ASCO25 this weekend! @JanWitowski will be presenting the results from our Ataraxis Breast clinical validation study--stop by to learn how our multi-modal AI and foundation models help personalize breast cancer treatment.
We are hiring for multiple engineering & research roles at Ataraxis AI! We recently raised a $20.4m Series A from top investors (AIX Ventures, Peter Thiel) and are quickly growing to help millions of cancer patients worldwide. Apply now at: jobs.ashbyhq.com/ataraxis-ai
Our team, including our CEO @JanWitowski, will be attending the 2025 J.P. Morgan Healthcare Conference #JPM2025 discussing our AI-native tools for treatment selection. Contact us to schedule a meeting: ataraxis.ai/contact-us
Yesterday, @JanWitowski presented the results of our 8,161-patient validation study of Ataraxis Breast at San Antonio Breast Cancer Symposium #SABCS24. Great turnout for results showing Ataraxis AI-native tests outperform genomic assays and work in all breast cancer subtypes.
We are at #SABCS24 next week: @JanWitowski will present results of the Ataraxis Breast validation study—first time in public. This 8161 patient study showed our AI predicts recurrence&survival in all breast cancer patients, and with ⬆️accuracy than SoC genomic test. Come meet us
We are coming to NeurIPS! @joecappadona will present results of our novel approach to training foundation models for digital pathology. This research goes beyond simply scaling model/data size, and led us to develop Kestrel, the model behind Ataraxis Breast. Come see us!
Anyone looking for a full stack engineer position? jobs.ashbyhq.com/ataraxis-ai/78… This is a great job in a great startup. You need to be a highly skilled computer scientist, have passion for coding and be relentless in pursuit of success. Please pass it to whoever might be interested!
Ataraxis is growing! We're now hiring for commercial, technical, medical and ops roles:
We are hiring at Ataraxis! Jobs: jobs.ashbyhq.com/ataraxis-ai The mission: apply advanced AI to one of the hardest problems in healthcare—optimizing treatment and predicting patient outcomes Looking for problem-solvers across all roles who want to build something meaningful
“If you don’t benefit from chemotherapy, you want to avoid it.” Our CEO @JanWitowski shared with Forbes' @TheAlexKnapp how Ataraxis Breast enables providers to recommend more precise, effective treatments—helping patients avoid unnecessary chemotherapy—and more.
EXCLUSIVE: Startup Ataraxis, which emerged from stealth Thursday, has developed a model that can predict the risk severity of breast cancer up to 30% more accurately than current tests. trib.al/Cur9UV6
United States Xu hướng
- 1. #StrangerThings5 285K posts
- 2. Thanksgiving 715K posts
- 3. BYERS 67K posts
- 4. robin 101K posts
- 5. Afghan 318K posts
- 6. Dustin 67.2K posts
- 7. Holly 68.7K posts
- 8. Reed Sheppard 6,748 posts
- 9. Vecna 66K posts
- 10. Jonathan 74.6K posts
- 11. Podz 5,114 posts
- 12. hopper 17K posts
- 13. Erica 19.2K posts
- 14. Nancy 69.6K posts
- 15. Lucas 84.9K posts
- 16. mike wheeler 10.5K posts
- 17. noah schnapp 9,285 posts
- 18. Joyce 34.6K posts
- 19. Tini 10.6K posts
- 20. derek 21K posts
Bạn có thể thích
Something went wrong.
Something went wrong.